Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Akero Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share | Rule 457(o) and Rule 457(r) (1) (2) | — | — | $200,000,000 | 0.0001102 | $22,040 | — | — | — | — | ||||||||||||
Fees Previously Paid | ||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | |||||||||||||
Total Offering Amounts | $200,000,000 | $22,040 | ||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||
Net Fee Due | $22,040 |
(1) | Calculated in accordance with Rule 457(b) and Rule 457(r) under the Securities Act of 1933, as amended. Represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form S-3ASR (Registration No. 333-256229) being paid herewith. |
(2) | The proposed maximum aggregate offering price is being used to calculate the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. |